Characterization of a Major Histocompatibility Complex Class II X-Box-Binding Protein Enhancing Tat-Induced Transcription Directed by the Human Immunodeficiency Virus Type 1 Long Terminal Repeat
暂无分享,去创建一个
Roberto Gambari | Monica Borgatti | R. Gambari | M. Borgatti | P. Giacomini | C. Mischiati | G. Feriotto | Carlo Mischiati | Giordana Feriotto | Patrizio Giacomini
[1] N. Hernandez,et al. Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs , 1993, Molecular and cellular biology.
[2] R. Gaynor,et al. Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression , 1994, Journal of virology.
[3] P. Sharp,et al. HIV‐1 Tat protein promotes formation of more‐processive elongation complexes. , 1991, The EMBO journal.
[4] M. Mathews,et al. HIV-1 Tat overcomes inefficient transcriptional elongation in vitro. , 1993, Journal of molecular biology.
[5] R. Roeder,et al. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.
[6] J. Ting,et al. Regulation of MHC gene expression. , 1993, Current opinion in immunology.
[7] B. Cullen. The HIV-1 Tat protein: An RNA sequence-specific processivity factor? , 1990, Cell.
[8] R. Gaynor,et al. Cellular transcription factors involved in the regulation of HIV-1 gene expression. , 1992, AIDS.
[9] R. Roeder,et al. Human transcription factor USF stimulates transcription through the initiator elements of the HIV‐1 and the Ad‐ML promoters. , 1993, The EMBO journal.
[10] R. Gambari,et al. Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNAase I footprinting study. , 1994, The Biochemical journal.
[11] R. Roeder,et al. An alternative pathway for transcription initiation involving TFII-I , 1993, Nature.
[12] W. Reith,et al. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X , 1988, Cell.
[13] B. Peterlin,et al. Affinity enrichment and functional characterization of TRAX1, a novel transcription activator and X1-sequence-binding protein of HLA-DRA , 1995, Molecular and cellular biology.
[14] B. Peterlin,et al. Control of RNA initiation and elongation at the HIV-1 promoter. , 1994, Annual review of biochemistry.
[15] K. Jeang,et al. Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat* , 1999, The Journal of Biological Chemistry.
[16] P. Cresswell. Questions of presentation , 1990, Nature.
[17] J. Guardiola,et al. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. , 1993, Critical reviews in immunology.
[18] J. Trowsdale,et al. Complete nucleotide sequence of a functional HLA-DPβ gene and the region between the DPβ1 and DPα1 genes: comparison of the 5′ ends of HLA class II genes , 1985 .
[19] C. Benoist,et al. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. , 1990, Annual review of immunology.
[20] P. Luciw,et al. Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters. , 1988, Genes & development.
[21] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[22] M. Nakanishi,et al. Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors , 1990, Molecular and cellular biology.
[23] A. Das. Control of transcription termination by RNA-binding proteins. , 1993, Annual review of biochemistry.
[24] D. Margolis,et al. Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production , 1994, Journal of virology.
[25] B. Durand,et al. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX , 1994, Molecular and cellular biology.
[26] C. Benoist,et al. The immune system of mice lacking conventional MHC class II molecules. , 1994, Advances in immunology.
[27] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[28] L. Glimcher,et al. Immune responses in MHC class II-deficient mice. , 1995, Annual Review of Immunology.
[29] J. Karn,et al. Tackling Tat. , 1999, Journal of molecular biology.
[30] R. Roeder,et al. Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro , 1994, Molecular and cellular biology.
[31] A. Frankel. Activation of HIV transcription by Tat , 1992, Current Biology.
[32] D Harrich,et al. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs , 1995, Journal of virology.
[33] M. Mathews,et al. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. , 1990, Genes & development.
[34] P. Sharp,et al. Novel mechanism and factor for regulation by HIV‐1 Tat. , 1995, The EMBO journal.
[35] R. Roeder,et al. Cooperative interaction of an initiator-binding transcription initiation factor and the helix–loop–helix activator USF , 1991, Nature.
[36] J. Karn,et al. Human immunodeficiency virus type 1 transactivator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[37] W. Reith,et al. Regulation of MHC class II genes: lessons from a disease. , 1996, Annual review of immunology.
[38] N. Zeleznik-Le,et al. Transcriptional regulation of the HLA-DRA gene. , 1991, Critical reviews in immunology.
[39] M. Mathews,et al. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation , 1989, Cell.
[40] L. Glimcher,et al. Sequences and factors: a guide to MHC class-II transcription. , 1992, Annual review of immunology.
[41] P. Sharp,et al. HIV TAR: An RNA enhancer? , 1989, Cell.
[42] Guangming Zhong,et al. Chlamydia Inhibits Interferon γ–inducible Major Histocompatibility Complex Class II Expression by Degradation of Upstream Stimulatory Factor 1 , 1999, The Journal of experimental medicine.
[43] R. Roeder,et al. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. , 1992, Genes & development.
[44] H. Wang,et al. Identification of two factors required for transcription of the ovalbumin gene , 1986, Molecular and cellular biology.